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Interpreting change on the SCAT3 in professional ice hockey players 
 
Abstract 
Objectives: To examine test-retest reliability of the SCAT3 for two consecutive seasons 
using a large sample of professional male ice hockey players, and to make recommendations 
for interpreting change on the test. 
Design: A cross-sectional descriptive study. 
Methods: Preseason baseline testing was administered in the beginning of the seasons 2013-
2014 and 2014-2015 to 179 professional male hockey players in rink side settings. 
Results: The test-retest reliabilities of the SCAT3 components were uniformly low. However, 
the majority of athletes remained grossly within their own individual performance range when 
two pre-season SCAT3 baseline scores were compared to published normative reference 
values. Being tested by the same person or a different person did not influence the results. It 
was uncommon for the Symptom score to worsen by  3 points, the Symptom Severity score 
to worsen by  5 points, SAC total score to worsen by  3 points, M-BESS total error points 
to increase by  3, or the time to complete Tandem Gait to increase by 4 seconds; each 
occurred in less than 10% of the sample. 
Conclusions: The SCAT3 has low test-retest reliability. Change scores should be interpreted 
with caution, and more research is needed to determine the clinical usefulness of the SCAT3 
for diagnosing concussion and monitoring recovery. Careful examination of the natural 
distributions of difference scores provides clinicians with useful information on how to 
interpret change on the test. 
 
Keywords: Brain Concussion, Head injuries, Baseline Survey, Ice Hockey  
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Introduction 
Head and brain injuries, especially concussions, are common and important health 
issues in collision sports. Ice hockey is a sport characterized by high velocity, rapid changes 
in direction, and injuries caused by collision with other players, boards, sticks, or pucks. The 
systematic collection of injury reports from team medical staff shows that the most commonly 
injured body region in professional male ice hockey is a player’s head.1,2 
The rink side or sideline recognition of sport-related concussion relies on a clinician’s 
evaluation. Injury mechanics, visible signs, reported symptoms, changes in cognitive and 
physical performance related to concussion, and exclusion of spinal injury are the key points 
of assessment. International guidelines for sport-related concussion recommend the use of the 
Sport Concussion Assessment Tool – Third edition (SCAT3) as a supportive instrument in 
concussion diagnostics.3-5 Post-injury SCAT3 scores are best interpreted when compared with 
either an accurate and reliable individual baseline or to age- and sport-specific normative data. 
6,7 
Annual pre-season concussion baseline testing (e.g., computer-based 
neuropsychological assessment) is common practice in many professional contact sports. 
However, there are very few published studies on how often baseline testing should be 
administered. For example, the SCAT3 is a widely used concussion assessment instrument 
that has no evidence-based guidelines regarding baseline testing frequencies or intervals. For 
accurate comparisons between post-injury and baseline performance, it is essential to know 
how consistent the test-retest results are (i.e. the reliability and stability of the baseline 
SCAT3 assessment over time). One factor that could influence reliability is learning effect. It 
is not known if SCAT3 performance is improved by learning when repeatedly done, and if so 
how long this learning effect lasts. 
4 
 
The purpose of this study was to examine the long-term test-retest reliability of SCAT3 
assessments in a realistic clinical setting to better understanding normal variation of the 
scores. We also aimed to describe if there is a significant difference between intra- and 
interrater reliability and whether the common practice of administering SCAT3 baseline on an 
annual basis is an ideal time frame or not. Suggestions for interpreting change on the SCAT3 
are offered.  
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Methods 
 This study is a part of a larger research project that strives to translate international 
recommendations regarding diagnosis and management of concussions into practice in 
Finnish professional ice hockey. Ethics approval for the study was obtained from the Ethical 
Committee of Pirkanmaa Hospital District, Tampere, Finland (code: R13070), and each 
participating subject signed written informed consent according to the Declaration of 
Helsinki. This study was financially supported by the Finnish Ministry of Education and 
Culture, the Finnish Hockey League, the Finnish Medical Foundation, and the Maire Taponen 
Foundation. There was no involvement with any commercial sponsor for this study regarding 
the study design; the collection, analysis, and interpretation of data; the writing of the report; 
or the decision to submit the paper for publication. 
 SCAT3 baseline testing became mandatory for all players in the highest Finnish 
professional male ice hockey league before the season 2013-2014, but there was not a 
requirement to do this annually. The total number of athletes playing in the league in two 
consecutive seasons (2013-2014 and 2014-2015) was 309. Only annually completed 
preseason SCAT3 baseline tests administered for seasons 2013-2014 and 2014-2015 were 
included in this study. The number of players who completed both pre-season SCAT3 
baseline tests was 179 (58%). Most of the players who were not included in the study 
completed only one baseline. A small number of athletes were not included for various 
reasons (e.g., being injured in the time of preseason baseline testing).  
In an effort to replicate how the SCAT3 assessment is given clinically, every player was 
tested individually, at least ten minutes after physical exertion, by the teams’ current medical 
staff, who were trained to administer SCAT3 in accordance with the SCAT3 instructions in 
regional training sessions led by the authors before the season 2013-2014. If a player had 
sustained a concussion prior to testing, he had to have been asymptomatic and participated at 
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least one month in normal game play after the concussion and before the SCAT3 baseline was 
administered. Demographic variables and medical history were obtained at the time of testing 
using the Background section of the SCAT3 form. Due to language difficulties with non-
Finnish and non-English speakers, this subgroup (n=8) was excluded from the statistical 
analysis of the symptom evaluation and the SAC components. The Finnish translation of the 
SCAT3 was accomplished by a professional translator and reviewed by the authors to 
maintain the original denotation and connotation of items instead of exact literal or syntactical 
equivalence.  
 Descriptive statistics [mean (M), median (Md), standard deviation (SD), interquartile 
range (IQR)] for both seasons and the individual differences between the test-retest results of 
the SCAT3 components were calculated. The relationships between five categorical 
background variables and test-retest differences were examined. Categorical background 
variables included: (i) examiner: same/different, (ii) age under 20-years: yes/no (iii) self-
reported history of concussions during seasons 2012-2013 and 2013-2014: yes/no, (iv) 
language of testing: native/non-native, (v) history of headache or migraine: yes/no. The data 
related to learning or attention problems (n=1) and psychiatric problems (n=1) could not be 
meaningfully analyzed due to small sample sizes. 
 The normality of the data was assessed using the Kolmogorov-Smirnov and Shapiro-
Wilk tests. The distribution of the scores in every component of the baseline SCAT3 were 
skewed so the correlations between two continuous variables were measured using the 
Spearman rho coefficient, Kendall’s tau b, and Wilcoxon Signed-Rank Test. Categorical 
variables in relation to continuous variables (individual test-retest absolute difference scores) 
were tested with the Mann-Whitney U-test (MWU). The level of statistical significance was 
set at 0.05. IBM SPSS Statistics 21.0 (IBM Corp. Armonk, NY, USA) was used to perform 
the analyses.  
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Results 
 The athletes were between the ages of 16 and 38 (M=25.4, SD=5.1) years and 19 
(10.6%) players were under 20 years before the first SCAT3 baseline test. The Finnish 
version of SCAT3 was used with 164 (95.9%) Finnish players; the others were tested with the 
English version. All athletes were Caucasian. The total number of medical staff who served as 
examiners was 33. More than one-third (35.8%, n=64) were tested by the same person before 
both seasons. The average time between athlete’s two baseline tests was 367 days (SD=24.2, 
IQR=360-378). A minority (n=25, 14%) of the players reported history of headache or 
migraine. A history of concussion was reported by 56.4% of the players, and 17.9% of all 
athletes reported having been hospitalized or undergone neuroimaging following a head 
trauma before the first SCAT3 baseline test. Eleven (6.6%) of them reported sustaining a 
concussion during the season (2012-2013) preceding the first SCAT3 baseline test in 2013. 
The number of athletes reporting a concussion between the two baselines was 31 (17.3%; i.e., 
during the 2013-2014 season or prior to preseason testing in 2014).  
The descriptive statistics and test-retest correlations for the SCAT3 components in two 
consecutive seasons are presented in Table 1. In general, at the group level, most of the 
SCAT3 mean baseline scores remained stable within the one-year interval. The test-retest 
correlations, however, were uniformly low, with 8/11 scores having a Spearman coefficient of 
0.3 or lower. We have previously published normative reference values for the SCAT3 
components.8 Those normative reference values were based on the pre-season SCAT3 test 
results of season 2013-2014 (n=304 athletes), and they are reprinted in Table 2. The 
percentages of the players who were categorized in the same normative classification range in 
both preseason baseline tests are presented in Table 3. As seen in column two, most of the 
players scored in the same normative classification range at both test and retest, and the large 
majority scored either in the same classification or a higher classification. 
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The distributions of the individual test-retest absolute difference scores are presented 
in Figures 1-6. The absolute difference scores of the SCAT3 components: Symptom score and 
severity, SAC, M-BESS, and Tandem gait had no statistically significant association with 
examiner (same/different), age (under/over 20 years), history of headache or migraine 
(yes/no), or self-reported history of concussion between baselines (yes/no). Better scores on 
concentration, a subcomponent of the SAC, were obtained by athletes that were tested by the 
same person in both baselines (positive ranks 45.3% vs. 29.5%; MWU=2817.5, p=0.01). All 
other subcomponents of SAC and M-BESS did not differ. Only three (1.7%) athletes failed 
the Coordination test on the first baseline test, and only four (2.2%) players failed the 
Coordination test during the second baseline. None of these players made errors on this test 
during both seasons. Over the two season baseline testing, none of the athletes made errors in 
the double leg stance of the M-BESS. 
Figure 1 illustrates the distribution of test-retest difference scores for all 
subcomponents of the SCAT3. By examining the values in the grey shaded regions to the left 
of each figure, it is possible to identify unusual worsening in performance (i.e., difference 
scores that are found in only 10% or 5% of uninjured athletes). Worsening means greater 
symptoms, greater error points on the M-BESS, greater time on the Tandem Gait, or lower 
scores on the SAC. Most athletes (75.6%) do not show test-retest changes of those 
magnitudes in any subcomponent of the SCAT3. More refined analyses of changes scores, for 
each SCAT3 component, are provided in Figures 2-6. As seen in Figure 2, an increase 
(worsening) of two or more symptoms at retest occurred in 14.7% of players, and an increase 
of three or more symptoms occurred in only 10%. As seen in Figure 3, a total symptom 
severity score that increases (worsens) by three or more points occurred in 14.1% of athletes, 
and an increase by five or more points occurred in only 8.8%. As seen in Figure 4, worsening 
of two or more points on the SAC occurs in 15.5% of professional athletes, and worsening of 
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three or more points occurs in only 7.2%. As seen in Figure 5, a worsening on the M-BESS 
(i.e., an increase in raw scores) by two or more points occurred in 16.7% of players, and a 
worsening by three or more points was uncommon, occurring in only 8.6% of players. As 
seen in Table 6, performing the Tandem Gait test more slowly, by three or more seconds, 
occurred in 18.2% of the players. Performing four or more seconds slower was uncommon, 
occurring in only 6.8% of players.  
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Discussion 
This large-scale study of the one-year test-retest reliability of the SCAT3 revealed 
several important findings for researchers and clinicians. First, the test-retest reliabilities of each 
component were uniformly low and mostly considered weak according to conventional standards for 
interpreting stability of human performance tests (see Table 1). The symptom scores had the largest 
test-retest correlations. These low correlations are related, in part, to the skewed distributions of the 
test scores. The limited number of options in the scoring of each SCAT3 component results in limited 
variability and ceiling effects (accumulation of the scores for a large percentage of people, usually to 
minimum and/or maximum score), which causes bias to reliability estimations and may reduce the 
magnitude of correlations. When tests, such as the SCAT3, are used for clinical decision making, it is 
important for the test to have adequate reliability and validity for the intended purpose and with the 
specific clinical population with which it is being used.9 The problems with reliability, illustrated in 
this study, are partially mitigated by having normative reference values (Table 2) and natural 
distributions of change scores (the Figures) for the SCAT3 components in professional hockey 
players. Second, the athletes’ level of performance, as a group (as reflected by mean and 
median scores), remained stable from test to retest across the components of the SCAT3. 
Nearly equal number of athletes showed improvement and declines over the test-retest 
interval for the Symptom score, Symptom Severity score, and Tandem Gait; in contrast, 
performance on the SAC and M-BESS was more likely to improve on the second baseline 
test. Third, there was no statistically significant difference related to whether the SCAT3 was 
administered by the same or a different examiner. Fourth, there were no differences in test-
retest difference scores in those who sustained a concussion between the two baseline 
assessments and those who did not. Finally, most players (i.e., 71-92%) obtained scores that 
were in the same normative classification range at both test and retest, based on the norms 
published by Hanninen and colleagues8. Moreover, retest scores were in the same or better 
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normative classification range in 86-96% of athletes. This means that when an athlete is tested 
a second time, it is very likely that his score will be similar to or better than it was previously. 
The information presented in Figures 1-6 is very useful for clinicians and researchers 
who want to better understand the natural distribution of test-retest difference scores on the 
SCAT3. This information can also be used to determine an unusual amount of change (i.e., 
worsening or improving) in SCAT3 performance in Finnish professional ice hockey players. 
Based on the current results, 10% or fewer of the athletes showed the following worsening of 
SCAT3 retest scores: an increase of three or more points on the Symptoms Score, an increase 
of five or more points on the Symptom Severity score, a worsening of three or more points on 
the SAC, an increase of three or more error points on the M-BESS, or an increase of four or 
more seconds on the Tandem Gait. Clinicians should note that professional hockey players 
perform perfectly or nearly perfectly on the Coordination test and the double-leg stance of the 
M-BESS, so errors on those tests should be considered abnormal. Clinicians can use the 
normative classification ranges in Table 2 in combination with these change scores. For 
example, as seen in Table 2, an increase of three symptoms or five points on symptom 
severity will usually result in a worsening in the normative classification, too. For the SAC, a 
decline by three or more points will always result in a worsening in the normative 
classification range, unless the person scores nearly perfectly at baseline (i.e., a score of 29 or 
30). For the M-BESS, an increase of three error points on retesting will often, but not always, 
result in a change in the normative classification range. The change scores presented in this 
paper might prove to be particularly useful for identifying deficits in athletes who perform 
nearly perfectly on baseline SAC and M-BESS testing, because those athletes could worsen in 
performance but still have scores that are considered broadly normal. 
It is important to note, however, that there are no validated rules or guidelines for 
interpreting change in performance on the SCAT3 in professional or amateur athletes. This 
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requires clinical judgment. For example, an athlete who reports headache and dizziness 
following a hard check into the boards, and who scores two points lower on the SAC (base 
rate = 15.5% in uninjured athletes) and obtains two more error points on the M-BESS (base 
rate = 16.6% in uninjured athletes) compared to his baseline might, in fact, be experiencing 
the acute effects of concussion even though his change scores are not in the grey area of 
Figures 4 and 5, respectively. The grey areas in the figures demarcate change scores that are 
statistically uncommon in uninjured athletes. The sensitivities of those change scores to the 
acute effects of concussion, however, are unknown.   
This study design was implemented in practical everyday life of professional ice 
hockey teams in order to maximize the generalizability and the applicability of the results. For 
this reason, we did not use independent external examiners. Additionally, we explored 
individual baseline performance changes and not only group level statistics. The strength of 
our study was the large sample size and the pragmatic study design. 
There are several limitations to this study. The athletes’ medical history was based on 
the SCAT3 form and therefore some relevant disease/injury history (e.g., lower limb injuries, 
sleep history) was not included. The information on previous concussions was solely based on 
self-report and it is known that athletes may underestimate their past concussions.10 The 
possibility of selection bias in player recruitment exists. Finally, we focused on a very narrow 
demographic group of professional athletes; additional research should be conducted on other 
sports, levels, genders, and age cohorts.  
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Conclusions 
The SCAT3 is designed to be used on the day-of-injury and in the initial days 
following injury. It is not designed to measure post-acute or long-term effects of concussion. 
There are no evidence-based guidelines regarding whether or not baseline preseason testing is 
necessary, and how often to do baseline testing (e.g., yearly or less frequently). More research 
is needed to determine the optimal frequency of baseline testing with the SCAT3, such as 
studies comparing reliability over different time periods and studies comparing post-injury 
scores to baseline scores after varying time intervals. It is reasonable to assume that the best 
way to interpret SCAT3 scores is a combination of comparing an athlete’s post-injury scores 
to a reliable personal baseline and to quality normative data. However, the SCAT3 has low 
test-retest reliability, making test-retest comparisons challenging. Careful examination of the 
natural distributions of difference scores provides clinicians and researchers with useful 
information on how to interpret change on the test. It is important for clinicians and 
researchers to appreciate that symptom scores can increase as a result of multiple factors 
separate from concussion, and some variability in test-retest performance is common on the 
performance-based measures (i.e., SAC, M-BESS, and Tandem Gait) in uninjured athletes.  
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Practical Implications 
x It is important to appreciate that SCAT3 symptom reporting can be affected by several 
factors separate from concussion, and some variability in the balance and cognition 
measures is common. 
x Despite low test-retest reliability of the SCAT3, most players have scores that fall within a 
similar normative classification range across a one-year test-retest interval. 
x Careful examination of the natural distributions of difference scores provides clinicians 
and researchers with useful information on what should be considered unusual or rare 
changes in performance in uninjured athletes.  
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Table 1. Descriptive statistics, effect sizes, and stability coefficients for the SCAT3.  
  Baseline 2013-2014 (test) Baseline 2014-2015 (retest)  
Test n M Md SD IQR Skew Kurt. M Md SD IQR Skew Kurt. rs tau b sig-r 
Symptom               
  Score 170 1.6 1 3.0 2 3.7 16.8 1.4 0 2.1 2 1.8 3.3 0.41 p<0.05 
0.36 
p<0.05 p=0.59 
  Severity 170 2.3 1 4.5 3 3.6 15.0 2.0 0 3.5 3 3.2 15.0 0.38 p<0.05 
0.33 
p<0.05 p=0.56 
SAC                 
  Total Score  169 27.0 27 1.7 2 -1.0 2.9 27.3 27 1.7 3 -0.4 -0.2 0.34 p<0.05 
0.27 
p<0.05 p=0.02 
  Orientation  170 4.9 5 0.4 0 -3.1 9.7 4.9 5 0.3 0 -3.4 9.6 -0.03 p=0.73 
-0.03 
p=0.73 p=0.08 
  Immediate Memory  170 14.6 15 0.6 1 -1.4 1.6 14.7 15 0.7 0 -2.8 9.3 0.25 p<0.05 
0.23 
p<0.05 p=0.06 
  Concentration  170 3.8 4 0.9 2 -0.1 -1.0 4.0 4 0.9 2 -0.4 -0.9 0.46 p<0.05 
0.40 
p<0.05 p=0.02 
  Delayed Recall 171 3.7 4 1.0 1 -0.7 0.6 3.7 4 1.2 2 -0.5 -0.7 0.33 p<0.05 
0.27 
p<0.05 p=0.91 
M-BESS                 
  Total  176 2.1 1.5 2.7 3 3.0 13.3 1.8 1 2.7 2 3.4 15.5 0.25  p<0.05 
0.21 
p<0.05 p=0.02 
  Single leg stance  178 1.4 1 1.7 2 2.5 9.6 1.2 1 1.7 2 3.1 12.4 0.19 p<0.05 
0.16 
p<0.05 p=0.01 
  Tandem stance 176 0.7 0 1.7 1 4.3 20.7 0.6 0 1.6 1 4.6 23.8 0.25 p<0.05 
0.24 
p<0.05 p=0.17 
Tandem Gait  44 10.8 11.2 1.7 2.5 -0.7 -0.4 10.8 11.0 1.5 2.7 -0.2 -1.1 0.04 p=0.78 
0.03 
p=0.81 p=0.96 
 
Note: n = sample size, M= mean, Md = median, SD = standard deviation, IQR = interquartile range, skew = skewness, Kurt. = kurtosis, rs = Spearman’s r, tau-b = Kendall’s 
tau b, and sig-r= Wilcoxon signed-rank test. Athletes did not make any errors in double leg stance for the M-BESS (legs together) so those values are not included in the table. 
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Table 2. Cutoff scores and classification ranges for the SCAT3 components for healthy professional male ice hockey players (n=304, from Hanninen et al., 
20168) 
 
 Broadly Normal Below Average/ Above Average 
Unusually Low/ 
Unusually High 
Extremely Low/ 
Extremely High 
 Cutoff % in this Range Cutoff 
% at or 
Below Cutoff 
% at or 
Below Cutoff 
% at or 
Below 
Symptom Score (0-22p)  0-2 80.3% 3 19.7% 4-10 9.9% 11+ 1.9% 
Symptom Severity (0-132p) 0-3 82.7% 4-5 17.3% 6-18 9.5% 19+ 1.8% 
SAC (0-30p) 26-30 83.5% 25 16.5% 24 8.6% 23- 1.8% 
   Orientation (0-5p) 5 92.2% N/A N/A 4 7.8% 3 1.4% 
   Immediate memory (0-15p)  14-15 93.7% N/A N/A 13 6.3% 12- 0.7% 
   Concentration (0-5p) 3-5 95.7% N/A N/A 2 4.3% 0-1 0% 
   Digits backward (0-4p)  3-4 97.5% N/A N/A 1 2.5% 0 0% 
   Delayed recall (0-5p) 3-5 88.1% 2 11.9% 1 4.6% 0 0.4% 
M-BESS (0-30 errors) 0-3 83.6% 4-5 16.6% 6-10 5.8% 11+ 2.0% 
   Single leg stance (0-10 errors) 0-2 82.4% 3 17.6% 4+ 9.3% N/A N/A 
   Tandem stance (0-10 errors) 0-1 90.9% N/A N/A 2-4 9.1% 5+ 2.0% 
Tandem gait (seconds) 12.1 76.6% 12.2-12.8 23.4% 12.9-13.9 9.6% 14.0+ 1.1% 
 
Classification ranges are based on the natural distribution of scores because the distributions were not normal. The goal was to select a below/above average cutoff that 
corresponded with the 25th and 75th percentile ranks, but this usually was not possible given the score distributions. Unusually low/high scores correspond with approximately 
the 10th and 90th percentile ranks, and extremely low/high scores correspond with approximately the 2nd and 98th percentile ranks. The classifications are worded differently 
based on the direction of the scoring for the SCAT3 component. Symptom scores and number of errors on the M-BESS are referred to as high and performance on cognitive 
testing and tandem gait are referred to as low. The months in reverse were stated correctly by 94.0% (n=265; not included as a row in Table 2). Abbreviations: p = points, 
SAC = Standardized Assessment of Concussion, and M-BESS = Modified Balance Error Scoring System. Adapted and reproduced with permission from: Hanninen T, 
Tuominen M, Parkkari J, et al. Sport concussion assessment tool - 3rd edition - normative reference values for professional ice hockey players. J Sci Med Sport 2016;19:636-
641. (To journal: we are in the process of requesting to adapt and reproduce this table). 
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Table 3. The percentages of the players who were categorized in the same (same or better) normative classification range as the previous 
preseason baseline test. 
 
 Total Sample Concussion between baselines Baseline tests performed by No Yes Different examiner Same examiner 
Symptom Score 72.4 (87.1) 70.7 (86.4) 80.0 (90.0) 72.5 (87.2) 72.1 (86.9) 
Symptom Severity 70.6 (85.9) 69.3 (85.0) 76.7 (90.0) 71.6 (86.2) 68.9 (85.2) 
SAC Total Score 76.8 (88.1) 76.8 (90.6) 76.7 (80.0) 72.0 (85.0) 85.2 (95.1) 
SAC Orientation 82.9 (89.4) 82.1 (93.6) 86.7 (93.3) 78.9 (90.8) 90.1 (98.4) 
SAC Immediate Memory 89.4 (94.7) 90.7 (96.4) 83.3 (86.7) 88.0 (93.5) 91.9 (96.8) 
SAC Concentration 92.3 (95.9) 92.1 (96.4) 93.3 (96.7) 91.6 (96.8) 93.5 (100) 
SAC Delayed Recall 74.2 (91.2) 75.9 (84.4) 66.7 (76.7) 75.2 (84.4) 72.6 (80.6) 
M-BESS Total errors 75.3 (90.8) 78.3 (93.7) 61.3 (77.4) 76.8 (99.0) 72.6 (91.9) 
M-BESS Single leg stance 77.4 (91.0) 79.4 (92.5) 67.7 (83.9) 77.4 (92.2) 77.4 (88.7) 
M-BESS Tandem stance 82.3 (92.6) 84.0 (95.1) 74.2 (80.6) 85.0 (92.0) 77.4 (93.5) 
Tandem Gait 72.7 (88.1) 70.3 (81.0) 85.7 (100) 66.7 (83.3) 80.0 (85.0) 
 
Note: Normative reference values from Hanninen and colleagues8, presented in Table 2, were used. Percentages who were in the same and same or better (in 
parentheses) classification range on retesting are presented for the total sample, for those who sustained a concussion between the two baselines, and for those 
tested by the same or a different examiner.  
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Figure 1. The distributions of individual test-retest absolute difference scores.  
 
  
Note: Athletes who had the exact same score (test-retest difference score = 0), better score (fewer symptoms; more points on the SAC; fewer errors on the M-
BESS; faster time in Tandem Gait), and worse score during the second baseline. Worse 10% and 5% in gray. Midmost 90% in dotted line box. 
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Figure 2. The distribution of individual test-retest absolute difference scores (Symptom Score) 
 
 
Note: Athletes who had the exact same score (test-retest difference score = 0), better score, and worse score in the second baseline. A worse score indicates an 
increase in number of symptoms reported. 
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Figure 3. The distribution of individual test-retest absolute difference scores (Symptom Severity) 
 
 
Note: Athletes who had the exact same score (test-retest difference score = 0), better score, and worse score in the second baseline. A worse score indicates an 
increase in severity of symptoms reported. 
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Figure 4. The distribution of individual test-retest absolute difference scores (SAC total) 
 
 
Note: Athletes who had the exact same score (test-retest difference score = 0), better score, and worse score in the second baseline. 
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Figure 5. The distribution of individual test-retest absolute difference errors (M-BESS total) 
 
Note: Athletes who had exact as many errors (test-retest difference errors = 0), less errors (better performance), and more errors (worse performance) in the 
second baseline.  
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Figure 6. The distribution of individual test-retest absolute difference time in seconds (Tandem Gait) 
 
Note: Athletes who had the exact same time in seconds (test-retest time difference = 0), better time, and worse time in the second baseline. 
 
 
 
 
